Sheff - I understand why you sold but why do you think EXEL and NAVB will drop lower? You think the markets are about to fall, bad chart for these two, or just a hunch?
EXEL FDA date is this month and NAVB is pretty low.
HEB has plenty of time to drop so I can see why you would think that one will drop lower.
Portfolio Update.. Market was down 140 points on last week so took advantage of some buying opportunities today on Friday 11/2/12. Will All positions were updated in the Intro Page at the close of the market day.
Alert..bought NPSP at $9.10 PDUFA date of Dec 30th for Gattex. Price target was raised from $13 to $15/share from Jefferies. Looking for 20-30% gains here into PDUFA. http://bit.ly/Qh7NYu
Alert..bought ACAD (2nd time) at $2.19 The company has 3 weeks until data is released for their 020 study. Expecting a solid catalyst move into the data release at end of November 2012. Looking for 15-20% gains before the data release.
Alert..bought CHTP at $1.54. Q4:12 Chelsea Therapeutics (CHTP) Clinical Data Top-line data for Phase 3 ‘306b trial/Northera at end of 2012. Looking for 10-15% gains into data release.
Alert..bought ALXA at $4.42. PDUFA date is 12/21/12. Looking for 10-15% gains into their approval date.
Market Data 
Markets 
AI
